Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Journal of Clinical Medicine|November 19, 2020
The Role of the Liquid Biopsy in Decision-Making for Patients with Non-Small Cell Lung CancerD Akhoundova, J Mosquera Martinez, L E Musmann, et al.
British Journal of Haematology|November 18, 2003
Smoldering multiple myeloma: natural history and recognition of an evolving typeL Rosiñol, J Bladé, J Esteve, et al.
Seminars in Oncology|April 30, 2003
Malignant transformation in IgM monoclonal gammopathy of undetermined significanceS Montoto, M Rozman, L Rosiñol, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 4, 2021
SEOM clinical guidelines for the treatment of malignant pleural mesothelioma (2020)E Nadal, J Bosch-Barrera, S Cedrés, et al.
Bone Marrow Transplantation|January 6, 2004
High-dose therapy/autologous stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remissionE Nadal, E Giné, J Bladé, et al.
Drug Design and Discovery|April 1, 1997
Synthesis and evaluation of new Reissert analogs as HIV-1 RT inhibitors. 2. Benzo[f]quinoline and pyridine derivativesA Monge, E Alvarez, C San Martín, et al.
Scientific Reports|September 2, 2017
A systematic analysis of orphan cyclins reveals CNTD2 as a new oncogenic driver in lung cancerL Gasa, A Sanchez-Botet, E Quandt, et al.
Cancer Treatment and Research Communications|April 27, 2021
RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysisS Ponce Aix, S Novello, E B Garon, et al.
Leukemia|March 16, 2007
Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacyM P Simula, S Marktel, C Fozza, et al.
Drug Design and Discovery|April 1, 1997
Synthesis and evaluation of new Reissert analogs as HIV-1 reverse transcriptase inhibitors. 1. Quinoline and quinoxaline derivativesM Font, A Monge, E Alvarez, et al.
Pageof 7